Back to results
Key Publications
April 18, 2014
Back to results
Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARgamma agonist.
Ann Med. 2014;46:18-23
Badeau RM, Honka MJ, Lautamäki R, Stewart M, Kangas AJ, Soininen P, Ala-Korpela M, Nuutila P